Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TE02102
- Development stage
- Preclinical
- Lead developer
- Jishi Tongguang Pharmaceutical Technology
- Modality
- iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies
- Administration
- Intravitreal
01
Overview
TE02102 is an investigational cell therapy consisting of induced pluripotent stem cell (iPSC)-derived 'youthful' retinal pigment epithelium (RPE) cells. Developed by TongEYE (Jishi Tongguang Pharmaceutical Technology (Ningbo) Co., Ltd.), TE02102 is designed as a regenerative therapy to replace damaged or lost RPE cells in patients with dry (atrophic) age-related macular degeneration (dry AMD). By transplanting healthy, functional RPE cells, the therapy aims to prevent the degeneration of photoreceptors and preserve visual function. TE02102 is currently being evaluated in investigator-initiated clinical trials (IIT) in China, with plans to advance toward an Investigational New Drug (IND) filing.
- Other names
- iPSC-derived retinal pigment epithelial cellsiPSC-derived retinal pigment epithelium cellsiPSC-derived youthful retinal pigment epithelium cellsiPSC-nRPECiPSC-RPEC
Beyond the preview
Go deeper on TE02102.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TE02102.